Browsing by Author "Fan, YH"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
Item type:Item, Design of a permanent/electromagnetic magnetic bearing-controlled rotor system(1997-05-01) ;Fan, YH ;Lee, AC ;Hsiao, FZ ;機械工程學系Department of Mechanical EngineeringThis study proposes design procedures for the permanent-magnet-biased magnetic bearings (PEMBs) in rotor systems. Many aspects of designing magnetic bearings are discussed, e.g. the selection of a permanent magnet material, dimensions of electromagnets and permanent magnets, gap length, load capacity and maximum Ampere-turns. Linearization and DC current driver are the two constraints for determining feasible designs. According to an analytical model with a rigid body assumption for the rotor-bearing system, a decentralized output feedback control algorithm is employed to control this inherently unstable magnetic suspension rotor system. Experimental results indicate that the controlled rotor performs well at rotor speeds up to 12,000 rpm. (C) 1997 Published by Elsevier Science Ltd.Item type:Item, Design of a permanent/electromagnetic magnetic bearing-controlled rotor system(1997-05-01) ;Fan, YH ;Lee, AC ;Hsiao, FZ ;交大名義發表機械工程學系This study proposes design procedures for the permanent-magnet-biased magnetic bearings (PEMBs) in rotor systems. Many aspects of designing magnetic bearings are discussed, e.g. the selection of a permanent magnet material, dimensions of electromagnets and permanent magnets, gap length, load capacity and maximum Ampere-turns. Linearization and DC current driver are the two constraints for determining feasible designs. According to an analytical model with a rigid body assumption for the rotor-bearing system, a decentralized output feedback control algorithm is employed to control this inherently unstable magnetic suspension rotor system. Experimental results indicate that the controlled rotor performs well at rotor speeds up to 12,000 rpm. (C) 1997 Published by Elsevier Science Ltd.Item type:Item, Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999(2004-01-01) ;Cheng, MF ;Yu, KW ;Tang, RB ;Fan, YHYang, YLSusceptibilities to amphotericin B and fluconazole of 383 Candida species isolated from blood were determined. Candida albicans was the most common species (55.6%), followed by Candida parapsilosis (17.5%), Candida tropicalis (16.5%), Candida glabrata (5.2%), Candida guilliermondii (2.3%), and others (2.9%). All but three isolates, Candida ciferrii, C. tropicalis, and C glabrata, one each, were susceptible to amphotericin B. A total of 367 (95.8%) and 15 (4.2%) isolates were susceptible and susceptible-dose dependent to fluconazole, respectively. Only one isolate, a C glabrata, was resistant to fluconazole. Few patients (13%) having prior fluconazole treatments may explain the low rate of resistance to fluconazole in this study. (C) 2004 Elsevier Inc. All rights reserved.Item type:Item, Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species(2005-04-07) ;Cheng, MF ;Yang, YL ;Yao, TJ ;Lin, CYLiu, JSBackground: Invasive fungal infections, such as candidemia, caused by Candida species have been increasing. Candidemia is not only associated with a high mortality (30% to 40%) but also extends the length of hospital stay and increases the costs of medical care. Sepsis caused by Candida species is clinically indistinguishable from bacterial infections. Although, the clinical presentations of the patients with candidemia caused by Candida albicans and non-albicans Candida species (NAC) are indistinguishable, the susceptibilities to antifungal agents of these species are different. In this study, we attempted to identify the risk factors for candidemia caused by C. albicans and NAC in the hope that this may guide initial empiric therapy. Methods: A retrospective chart review was conducted during 1996 to 1999 at the Veterans General Hospital-Taipei. Results: There were 130 fatal cases of candidemia, including 68 patients with C. albicans and 62 with NAC. Candidemia was the most likely cause of death in 55 of the 130 patients (42.3%). There was no significant difference in the distribution of Candida species between those died of candidemia and those died of underlying conditions. Patients who had one of the following conditions were more likely to have C. albicans, age >= 65 years, immunosuppression accounted to prior use of steroids, leukocytosis, in the intensive care unit (ICU), and intravascular and urinary catheters. Patients who had undergone cancer chemotherapy often appeared less critically ill and were more likely to have NAC. Conclusion: Clinical and epidemiological differences in the risk factors between candidemia caused by C. albicans and NAC may provide helpful clues to initiate empiric therapy for patients infected with C. albicans versus NAC.